超早産児(妊娠22週~23週)の生存率・罹患率の国際コホート研究~各国・地域で大きな隔たりがあり、日本はトップクラスの成績~

ad

2025-11-11 成育医療研究センター

国立成育医療研究センターを中心とする国際共同研究チームは、妊娠22〜23週で出生した超早産児の生存率と罹患率を12か国・地域の新生児ネットワークで比較解析した。対象は2015〜2021年にNICUへ入院した5019人で、妊娠22週では退院生存率が9〜64%、23週では16〜80%と国により大きな差があった。重症の脳室周囲出血(PVH)または脳室周囲白質軟化症(PVL)の罹患率は22週で24〜65%、23週で18〜56%、壊死性腸炎(NEC)は6〜28%(23週のみ)と報告された。日本は生存率が高く、重度脳障害の発症率も低く、全体でトップクラスの成績を示した。これらの違いは医療制度や診療体制の差が影響している可能性があり、日本の高度な新生児医療技術が国際的な医療の質向上に貢献すると期待される。本成果は米国医学誌『JAMA Pediatrics』に掲載された。

超早産児(妊娠22週~23週)の生存率・罹患率の国際コホート研究~各国・地域で大きな隔たりがあり、日本はトップクラスの成績~

<関連情報>

11の国際新生児ネットワークにおける妊娠22~23週で生まれた早産児の転帰 Outcomes of Preterm Infants Born at 22 to 23 Weeks’ Gestation in 11 International Neonatal Networks

Tetsuya Isayama, MD, PhD; Mikael Norman, MD, PhD; Satoshi Kusuda, MD;et al
JAMA Pediatrics  Published:August 25, 2025
DOI:10.1001/jamapediatrics.2025.2958

Key Points

Question What are the rates of survival and major morbidity in infants born at 22 to 23 weeks’ gestation and admitted for neonatal intensive care?

Findings In this international registry-based cohort study of 11 neonatal networks, significant variations were observed in adjusted probabilities of outcomes for 846 infants born at 22 weeks’ gestation and 4173 born at 23 weeks’ gestation, including survival to discharge (9%-64% and 16%-80%), severe periventricular hemorrhage or periventricular leukomalacia (24%-65% and 18%-56%), and treated retinopathy (32%-57% and 16%-48%), respectively.

Meaning Significant between-network variations exist in survival and morbidity in infants born at 22 and 23 weeks’ gestational age, for which explanation will require evaluation of patients, caregivers, systems, and processes.

Abstract

Importance Postnatal intensive care for preterm infants born at 22 to 23 weeks’ gestation is increasing, although survival rates remain low. Information on outcomes for multiple countries or regions can be important for research, benchmarking, quality improvement, and parental counseling.

Objective To evaluate survival and major morbidities and their between-network variations in infants born at 22 to 23 weeks’ gestation in 11 neonatal networks participating in the International Network for Evaluation of Outcomes (iNeo) in neonates in 12 countries or regions.

Design, Setting, and Participants International registry-based cohort study of infants born at 22 to 23 weeks’ gestation from January 1, 2015, through December 31, 2021, without major congenital anomalies who were admitted for neonatal intensive care in 11 national or regional neonatal consortia. Data analysis was performed from December 2, 2023, to June 15, 2025.

Exposures Neonatal consortium and gestational age at birth.

Main Outcomes and Measures Survival to neonatal intensive care unit discharge, major neonatal morbidities, and survival without any major morbidities.

Results A total of 5019 neonates were included (1084 of 4636 neonates [23%] with a maternal age >35 years; 2641 of 5017 neonates [53%] male); among them, 846 neonates were born at 22 weeks’ gestation and 4173 were born at 23 weeks’ gestation. Variations between contributing networks for perinatal management at 22 and 23 weeks’ gestation, respectively, include any antenatal steroids (ranges of 18%-83% and 57%-98%), cesarean birth (0%-42% and 5%-73%), and outborn (0%-26% and 0%-22%). Significant variations between contributing networks for adjusted probabilities of outcomes at 22 and 23 weeks’ gestation, respectively, include survival to discharge (95% CIs of 9%-64% and 16%-80%; P < .001), grade 3 or 4 periventricular hemorrhage (PVH) or periventricular leukomalacia (PVL) (severe PVH or PVL: 24%-65% and 18%-56%; P < .001), survival without severe PVH or PVL (7%-53% and 9%-69%; P < .001), treated retinopathy of prematurity among survivors (32%-57% [P = .008] and 16%-48% [P < .001]), bronchopulmonary dysplasia among survivors (for 23 weeks only: 64%-88%; P < .001), and necrotizing enterocolitis (for 23 weeks only: 6%-28%; P < .001). Standardized incidence ratios showed significant differences in survival and major morbidities in some networks compared with a reference population from all other networks.

Conclusions Substantial international variations were identified in outcomes for infants born at 22 to 23 weeks’ gestation who were admitted to 11 neonatal networks in the 12 countries or regions. The variations can be due to differences in systems, care practices, attitudes, and culture; however, identification of variation can help focus efforts toward research aimed at understanding the causal determinants of variation.

 

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました